Monclip BM Tablet contains Bambuterol 10 mg and Montelukast 10 mg, a dual-action respiratory formulation designed for effective management of bronchial conditions and asthma.
Bambuterol acts as a long-acting bronchodilator, relaxing airway smooth muscles and improving airflow. Montelukast works as a leukotriene receptor antagonist, reducing allergic inflammation and preventing bronchospasm, making it effective in chronic asthma and allergy management.
Clinically, Monclip BM Tablet is indicated for asthma, allergic rhinitis, and obstructive airway disorders, providing enhanced breathing, reduced inflammation, and better patient compliance through its convenient tablet form.
From a business perspective, Monclip BM Tablet strengthens the respiratory therapy segment, widely used in clinics, hospitals, and pulmonary care centers, offering consistent demand, repeat prescriptions, and strong prescriber confidence.